Skip to content
Login
Search:
CROI Conference
CROI ConferenceCROI Conference
  • About CROI
    • CROI 2027 Important Dates
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • CROI Abstract Categories
    • Abstract Guidelines and Submission
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Who Can Attend
    • Letter Of Invitation (For Visa And Other Purposes)
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
  • Program
    • CROI 2027 Program
    • Our Voices
    • Media
    • Embargo Policies And Press Release Policies
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • About CROI
    • CROI 2026 Preliminary Important Dates and Deadlines
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • Abstract Guidelines and Submission
    • CROI Abstract Categories
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Oral Abstract Presentation Guidelines
    • Poster Presentation Guidelines
    • Themed Discussion Guidelines
    • Plain Language Summaries: A Mile-High View at CROI 2026
    • People-First Language and the Use of Appropriate Terminology
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Registration
    • Who Can Attend
    • Media Accreditation and Registration
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
    • Scholarship Travel
  • Program
    • CROI 2027 Program
    • CROI 2026 Resources
    • Our Voices
    • Media
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • CROI 2027 Important Dates

Search Results for: node/PEP: Remember Me?

DOXYPEP & ANTIMICROBIAL RESISTANCE IN N. GONORRHOEAE, COMMENSAL NEISSERIA & S. AUREUS

By Jimmy He PharmD, DScMarch 24, 2023

Background: Doxycycline post-exposure prophylaxis (doxy-PEP) is highly effective in reducing N. gonorrhoeae (GC), C. trachomatis (CT), and syphilis among men who have sex with men (MSM) and transgender women (TGW)….

ARE ROUTINE RENAL AND LIVER LABS TESTING AMONG PEP PATIENTS ON TDF/FTC/DTV NECESSARY?

By Enthusiast Inc MDMarch 7, 2019

…NYC SHC. We extracted medical record data from PEP initiation visits during 9/2016-12/2017 with: TDF/FTC/DTV regimen, a baseline metabolic panel, and no HIV medication dispensed in the prior three months…

1043 – DoxyPEP Effectiveness: Identifying Dosing Thresholds and High-Risk Contexts

By Jimmy He PharmD, DScMarch 31, 2026

…doxyPEP doses required to observe a measurable reduction in bSTI incidence, and (iii) to explore the contexts in which its use may be most appropriately targeted. Methods This retrospective analysis…

Doxy-PEP Associated With Declines in Chlamydia and Syphilis in MSM and Trans Women in San Francisco

By Jimmy He PharmD, DScApril 26, 2024

…with men (MSM) and transgender women (TGW) with a history of sexually transmitted infections (STIs) or multiple sex partners. Doxy-PEP’s effect on population-level incidence of STIs is unknown. Methods: To…

1041 – Potential Impact of DoxyPEP and Decreased STI Screening & Partner Treatment on Antibiotic Use in MSM

By Jimmy He PharmD, DScApril 1, 2026

…of GC/CT screening and empiric therapy (Antimicrobial Stewardship) without doxy PEP, Current Practice with doxyPEP, and Antimicrobial Stewardship with doxyPEP.  For doxyPEP models, we assumed 30% doxyPEP use among MSM…

LRA TREATMENT ALTERS ANTIGEN PROCESSING AND PEPTIDE PRESENTATION IN CD4 T CELLS

By Enthusiast Inc MDMarch 5, 2018

…peptides in cytosolic extracts from LRA-treated primary CD4 T cells yielded altered degradation patterns with 4-8 sites significantly changed in a 35-mer and 2-4 in a 24-mer depending on the…

The Impact of PEPFAR Abstinence and Faithfulness Funding Upon HIV Risk Behaviors in Sub-Saharan Africa

By Enthusiast Inc MDFebruary 24, 2015

…living in PEPFAR funded and non-PEPFAR countries from 1998 to 2013. Results: We analyzed 252,251 men and 591,714 women using 54 surveys in 14 PEPFAR funded and 8 non-PEPFAR funded…

1046 – Evaluation of DoxyPEP Consumption in a PrEP Cohort After Structured Counseling

By Jimmy He PharmD, DScMarch 31, 2026

…and bSTI prevalence were assessed using generalized estimating equations. Results A total of 338 men who have sex with men were included, with a median age of 35 (IQR 30-41)…

A Matter of Time: Factors Associated With Delayed nPEP Initiation

By Jimmy He PharmD, DScMarch 6, 2024

…to our Emergency Department (ED) asking for nPEP. Methods: Retrospective Monocentric Observational study including all individuals who consecutively accessed our ED asking for nPEP between January 2011 and July 2023….

902 – HIV and STI Trends With Rising PrEP and Emerging Doxy-PEP Use Among MSM in Tokyo, 2017-2025

By Jimmy He PharmD, DScMarch 31, 2026

Background HIV pre-exposure prophylaxis (PrEP) and doxycycline post-exposure prophylaxis (Doxy-PEP) are increasingly adopted by gay and bisexual men worldwide, but real-world evidence on their population impact remains limited, particularly in…

←1
2
…34567…
8910111213141516171819202122232425262728293031323334353637383940414243444546474849505152535455565758596061626364656667686970717273747576777879808182
83→
Copyright © 2026 CROI Foundation/IAS-USA. All Rights Reserved.
Website by Enthusiast, Inc.
  • About CROI
  • Presenters
  • Abstracts
  • Scholarships
  • Program
Footer Menu
Go to Top